Effects of topical administration of 1% brinzolamide on normal cat eyes

Veterinary Ophthalmology

Volumn 6, Issue 4, 2003, Pages 285-290

  Gray, H E ^a   Willis, A M ^b   Morgan, R V ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b Animal Vision of Avon   (United States)

^c Smoky Mountain Veterinary Services   (United States)

Author keywords

Brinzolamide; Carbonic anhydrase inhibitor; Cats; Glaucoma; Intraocular pressure

Indexed keywords

BRINZOLAMIDE;

ARTICLE; BLOOD PRESSURE; CAT; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; EYE; FOLLOW UP; INTRAOCULAR PRESSURE; LINEAR REGRESSION ANALYSIS; NONHUMAN; PUPIL; RANDOMIZATION;

ADMINISTRATION, TOPICAL; ANIMALS; CARBONIC ANHYDRASE INHIBITORS; CATS; FEMALE; INTRAOCULAR PRESSURE; MALE; OPHTHALMIC SOLUTIONS; REFERENCE VALUES; SULFONAMIDES; THIAZINES;

ANIMALIA; FELIS CATUS;

EID: 0346848652     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2003.00308.x     Document Type: Article

References (48)

1. Blocker T, van der Woerdt A. The feline glaucomas: 82 cases 1995-1999. Veterinary Ophthalmology 2001; 4: 81-85.
2. Glaze MB, Gelatt KN. Feline ophthalmology. In: Veterinary Ophthalmology, 3rd edn. (ed. Gelatt KN) Lippincott, Williams & Wilkins, Baltimore, 1999; 997-1052.
3. Barnett KC, Crispin SM. Feline Ophthalmology. W.B. Saunders Co. Ltd, Philadelphia, 1998.
4. Brooks DE. Glaucoma in the dog and cat. Veterinary Clinics of North America 1990; 20: 775-797.
5. Wilcock BP, Peiffer RL, Davidson MG. The causes of glaucoma in cats. Veterinary Pathology 1990; 27: 35-40.
6. Boyle JE, Ghosh K, Gieser DK, Adamsons IA. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Ophthalmology 1998; 105: 1945-1951.
7. Rainbow ME, Dziezyc J. Effects of 2% dorzolamide on intraocular pressure in cats (Abstract). 32nd Annual Meeting of the American College of Veterinary Ophthalmologists 2001; 4: 298.
8. Macknight ADC, McLaughlin CW, Peart D et al. Formation of the aqueous humor. Clinical and Experimental Pharmacology and Physiology 2000; 27: 100-106.
9. Becker B. Carbonic anhydrase and the formation of aqueous humor. American Journal of Ophthalmology 1959; 47: 342.
10. Caprioli J. The ciliary epithelia and aqueous humor. In: Adler's Physiology of the Eye, 9th edn. (ed. Hart WM, Jr) Mosby-Year Book, Inc, St Louis, 1992; 228-247.
11. Larsson LI, Rettig ES, Brubaker RF. Aqueous flow in open-angle glaucoma. Archives of Ophthalmology 1995; 113: 283-286.
12. Larsson LI, Rettig ES, Sheridan PT et al. Aqueous humor dynamics in low-tension glaucoma. American Journal of Ophthalmology 1993; 116: 590-593.
13. Gelatt KN, MacKay EO. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. Veterinary Ophthalmology 2001; 4: 61-67.
14. Gillies WE, Brooks AM. A trial of dorzolamide for glaucoma. Ophthalmic Surgery and Lasers 1998; 29: 728-732.
15. Wang RF, Serle JB, Podos SM et al. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Archives of Ophthalmology 1991; 109: 1297-1299.
16. Havener WH. Autonomic drugs. In: Ocular Pharmacology, (ed. Havener WH) CV Mosby Co, St Louis, 1986; 261-417.
17. Starita RJ, Piltz-Seymour JR, Fellman RL. Ocular and systemic side effects of carbonic anhydrase inhibitors. In: Complications of Glaucoma Therapy, (eds Sherwood MB, Spaeth GL) Slack Inc, Thorofare, 1990; 57-76.
18. Mogk LG, Cyrlin MW. Blood dyscrasias and carbonic anhydrase inhibitors. Ophthalmology 1988; 95: 768-771.
19. Gelatt KN, Brooks DE. The canine glaucomas. In: Veterinary Ophthalmology, 3rd edn. (ed. Gelatt KN) Lippincott, Williams & Wilkins, Baltimore, 1999; 701-754.
20. Gum GG. Physiology of the eye. In: Veterinary Ophthalmology, 2nd edn. (ed. Gelatt KN) Lea & Febiger, Philadelphia, 1991; 124-161.
21. Pfeiffer N. Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor. Survey of Ophthalmology 1997; 42: 137-151.
22. Ingram CJ, Brubaker RF. Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes. American Journal of Ophthalmology 1999; 128: 292-296.
23. Hutzelmann J, Owens S, Shedden A et al. Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. British Journal of Ophthalmology 1998; 82: 1249-1253.
24. Rosenberg LF, Krupin T, Tang LZ et al. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. Ophthalmology 1998; 105: 92-93.
25. Silver LH. Clinical efficacy and safety of brinzolamide, a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. American Journal of Ophthalmology 1998; 126: 400-408.
26. Maus TL, Larsson LI, McLaren JW et al. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Archives of Ophthalmology 1997; 115: 45-49.
27. Cawrse MA, Ward DA, Hendrix DVH. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. American Journal of Veterinary Research 2001; 62: 859-863.
28. Whelan NC, Welch P, Pace A et al. A comparison of the efficacy of topical brinzolamide and dorzolamide alone and in combination with oral methazolamide in decreasing normal canine intraocular pressure (Abstract). 30th Annual Meeting of the American College of Veterinary Ophthalmologists 1999; 2: 267-268.
29. Barnes GE, Li B, Dean T et al. Increase of optic nerve head blood flow after 1 week of topical brinzolamide treatment in Dutch-Belted rabbits. Survey of Ophthalmology 2000; 44 (Suppl. 2): S131-S140.
30. Fanous MM, Challa P, Maren TH. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit. Journal of Ocular Pharmacology and Therapeutics 1999; 15: 51-57.
31. Willis AM, Robbin TE, Hoshaw-Woodard S et al. Effect of topical administration of 2% dorzolamide hydrochloride or 2% dorzolamide hydrochloride - 0.5% timolol maleate on intraocular pressure in clinically normal horses. American Journal of Veterinary Research 2001; 62: 709-713.
32. Herkel U, Pfeiffer N. Update on topical carbonic anhydrase inhibitors. Current Opinions in Ophthalmology 2001; 12: 88-93.
33. Wilkerson M, Cyrlin M, Lippa EA et al. Four-week safety and efficacy study of dorzolamide, a novel, active carbonic anhydrase inhibitor. Archives of Ophthalmology 1993; 111: 1343-1350.
34. Lippa EA, Carlson LE, Ehinger B et al. Dose-response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Archives of Ophthalmology 1992; 110: 495-499.
35. DeSantis L. Preclinical overview of brinzolamide. Survey of Ophthalmology 2000; 44 (Suppl. 2): S112-S129.
36. Silver LH. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Survey of Ophthalmology 2000; 44 (Suppl. 2): S147-S153.
37. Michaud JE, Friren B. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. American Journal of Ophthalmology 2001; 132: 235-243.
38. Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Progress in Retina and Eye Research 2000; 19: 87-112.
39. Sall K. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Survey of Ophthalmology 2000: 44 (Suppl 2): S155-S162.
40. Bill A. Formation and drainage of aqueous humor in cats. Experimental Eye Research 1966; 5: 185-190.
41. Ward DA, Cawrse MA, Hendrix DV. Fluorophotometric determination of aqueous humor flow rate in clinically normal dogs. American Journal of Veterinary Research 2001; 62: 853-858.
42. King TC, Gum GG, Gelatt KN. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles. American Journal of Veterinary Research 1991; 52: 2067-2070.
43. Gelatt KN, Gum GG, Williams LW et al. Ocular hypotensive effects of CAI in normotensive and glaucomatous beagles. American Journal of Veterinary Research 1979; 40: 334-345.
44. Kroll MM, Miller PE, Rodan I. Intraocular pressure measurements attained as part of a comprehensive geriatric health examination from cats 7 years of age or older. Journal of the American Veterinary Medical Association 2001; 219: 1406-1410.
45. Miller PE, Pickett JP. Comparison of the human and canine Schiotz tonometry conversion tables in clinically normal cats. Journal of the American Veterinary Medical Association 1992; 201: 1017-1020.
46. Miller PE, Pickett JP, Majors LJ et al. Evaluation of two applanation tonometers in cats. American Journal of Veterinary Research 1991; 52: 1917-1921.
47. Harris BP, Ramsey D, Hauptman JG. Effect of age on intraocular pressure in cats (Abstract). 30th Annual Meeting of the American College of Veterinary Ophthalmologists 1999; 2: 261.
48. Toris CB, Yablonski ME, Wang YL et al. Aqueous humor dynamics in the aging human eye. American Journal of Ophthalmology 1999; 127: 407-412.